צמיחת מכירות משנה לשנה ב-12 החודשים האחרונים: Ainos, Inc. (AIMD)

Ainos, Inc. (AIMD) develops AI platforms and "digital nose" biosensors for precision diagnostics. Patents for portable systems and stringent regulatory requirements create significant market barriers. Management of the Taiwanese biotech firm is currently focusing on the commercial scaling of sales. The annual revenue growth trend over a rolling 12-month period confirms this data, where 479.90 forms the current metric value.
Ainos Inc (AIMD) - פילוחי מדדים ודוחות פיננסיים

This indicator calculates the percentage change in revenue over the last 12 months relative to the same period last year. The metric measures the current pace of business expansion, allowing for an assessment of the company's operational resilience. For Ainos, Inc. (AIMD), this growth reflects the successful commercialization of diagnostic systems and cloud monitoring services. The positive trend confirms the effectiveness of management's innovation strategy. By analyzing the history of sales dynamics over the last 12 months versus the same period last year, an investor can forecast the future value of the shares.